These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 14555277

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population.
    Nagata N, Kitaura H, Yoshida N, Nakayama K.
    Bone; 2003 Oct; 33(4):721-32. PubMed ID: 14555278
    [Abstract] [Full Text] [Related]

  • 3. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
    Dai SM, Nishioka K, Yudoh K.
    Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
    [Abstract] [Full Text] [Related]

  • 4. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H, Härkönen PL, Väänänen HK, Hentunen TA.
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [Abstract] [Full Text] [Related]

  • 5. Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos.
    Grcević D, Lukić IK, Kovacić N, Ivcević S, Katavić V, Marusić A.
    Clin Exp Immunol; 2006 Oct; 146(1):146-58. PubMed ID: 16968409
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation.
    Kim MS, Day CJ, Morrison NA.
    J Biol Chem; 2005 Apr 22; 280(16):16163-9. PubMed ID: 15722361
    [Abstract] [Full Text] [Related]

  • 9. The generation of highly enriched osteoclast-lineage cell populations.
    Quinn JM, Whitty GA, Byrne RJ, Gillespie MT, Hamilton JA.
    Bone; 2002 Jan 22; 30(1):164-70. PubMed ID: 11792580
    [Abstract] [Full Text] [Related]

  • 10. Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8(+) T cells.
    Choi Y, Woo KM, Ko SH, Lee YJ, Park SJ, Kim HM, Kwon BS.
    Eur J Immunol; 2001 Jul 22; 31(7):2179-88. PubMed ID: 11449372
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prostaglandin E2 strongly inhibits human osteoclast formation.
    Take I, Kobayashi Y, Yamamoto Y, Tsuboi H, Ochi T, Uematsu S, Okafuji N, Kurihara S, Udagawa N, Takahashi N.
    Endocrinology; 2005 Dec 22; 146(12):5204-14. PubMed ID: 16150915
    [Abstract] [Full Text] [Related]

  • 14. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
    Xing L, Bushnell TP, Carlson L, Tai Z, Tondravi M, Siebenlist U, Young F, Boyce BF.
    J Bone Miner Res; 2002 Jul 22; 17(7):1200-10. PubMed ID: 12096833
    [Abstract] [Full Text] [Related]

  • 15. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ.
    J Bone Miner Res; 2000 Aug 22; 15(8):1459-66. PubMed ID: 10934644
    [Abstract] [Full Text] [Related]

  • 16. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K, Udagawa N, Matsuzaki K, Takami M, Amano H, Shinki T, Ueno Y, Takahashi N, Suda T.
    J Bone Miner Res; 2000 Sep 22; 15(9):1766-75. PubMed ID: 10976996
    [Abstract] [Full Text] [Related]

  • 17. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D, Katagiri M, Ogasawara T, Ogata N, Shimoaka T, Takato T, Nakamura K, Kawaguchi H.
    J Bone Miner Res; 2001 Nov 22; 16(11):2074-81. PubMed ID: 11697804
    [Abstract] [Full Text] [Related]

  • 18. Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor.
    Kaneda T, Nojima T, Nakagawa M, Ogasawara A, Kaneko H, Sato T, Mano H, Kumegawa M, Hakeda Y.
    J Immunol; 2000 Oct 15; 165(8):4254-63. PubMed ID: 11035059
    [Abstract] [Full Text] [Related]

  • 19. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
    Kindle L, Rothe L, Kriss M, Osdoby P, Collin-Osdoby P.
    J Bone Miner Res; 2006 Feb 15; 21(2):193-206. PubMed ID: 16418775
    [Abstract] [Full Text] [Related]

  • 20. Gene array identification of osteoclast genes: differential inhibition of osteoclastogenesis by cyclosporin A and granulocyte macrophage colony stimulating factor.
    Day CJ, Kim MS, Stephens SR, Simcock WE, Aitken CJ, Nicholson GC, Morrison NA.
    J Cell Biochem; 2004 Feb 01; 91(2):303-15. PubMed ID: 14743390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.